September 2012 Editor's Picks: Products from Uhlmann Packaging Systems and GE Healthcare - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

September 2012 Editor's Picks: Products from Uhlmann Packaging Systems and GE Healthcare

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Uhlmann Packaging Systems
Integrated blister and carton module features simplified changeover

Uhlmann Packaging Systems’ Blister Express Center 500 (BEC 500) is a double-lane, integrated blister and carton module that can process up to 500 blisters and 500 cartons per minute, which makes it ideal for packaging medium-sized batches of standard, solid-dose products. The flexible machine is available with rotary or platen sealing and can produce complex shapes, rigid aluminum pockets, calendar packs, and other nontraditional packages. Between runs, the machine features a newly simplified changeover process that allows a single person to completely reset the entire line in just 30 minutes without the use of tools. Uhlmann’s new SmartControl operating system offers step-by-step guidance through the entire format changeover.


GE Healthcare
Modular, prefabricated bioprocessing facility reduces construction time and capital investment compared to traditional facilities


GE Healthcare’s KUBio modular, 1200-m2 bioprocessing facility is prefabricated and delivered with a complete, ready-to-use production line that is based on GE Healthcare’s Ready-to-Process single-use technologies. The total planning, delivery, and construction time of the facility is 14–18 months, which is significantly less than the 24–36 months needed for traditional construction. Capital investment is also significantly reduced.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Equipment and Processing Report,
Click here